Literature DB >> 12893982

Functional significance of a hereditary adenine insertion variant in the 5'-UTR of the endothelin-1 gene.

Katrin Popowski1, Bernhard Sperker, Heyo K Kroemer, Ulrich John, Michael Laule, Karl Stangl, Ingolf Cascorbi.   

Abstract

Endothelin-1 (ET-1) is known as a potent vasoconstrictor peptide and stimulator of cell proliferation. The human preproendothelin-1 mRNA contains a frequent adenine insertion polymorphism (allele frequency = 0.28) within the 5'-untranslated region (5'-UTR), 138 bp downstream of the transcription start site, which was assumed to be related to hypertension. This 5'-UTR variant could putatively influence the mRNA secondary structure and stability, efficacy of translation initiation, or binding of sequence-specific mRNA-binding proteins. By cloning the entire ET-1 gene 5'-UTR in a pGL3 vector and transfection of two cell lines, we studied the effects on luciferase expression in vitro. Luciferase activity was significantly increased in the insertion variant (I) compared to the wild-type (D) variant for both COS1 (2.97 +/- 0.12 versus 2.17 +/- 0.10; P = 0.002) and HepG2 cells (5.42 +/- 0.90 versus 3.68 +/- 0.37; P = 0.002). Investigations performed ex vivo using human umbilical vein endothelial cells were performed to examine the influence of genotypes on the formation of mRNA and protein. Preproendothelin-1-mRNA was quantified in relation to GAPDH by a realtime polymerase chain reaction. Homozygous I-carriers showed significant elevated mRNA levels compared to I/D and I/I-carriers (I/I 9.03 +/- 1.86, I/D 2.07 +/- 1.15, D/D 2.33 +/- 0.99; P = 0.001). ET-1 protein expression, determined by enzyme-linked immunosorbent assay, was increased among I-carriers (I/I 814 +/- 144, I/D 528 +/- 103, D/D 556 +/- 75 pg/ml; P = 0.001). The observed effects may be due to an enhanced mRNA stability because the half-life of mRNA consisting of the I-variant was prolonged (35.4 +/- 7.9 versus 19.9 +/- 4.5 min). We were able to show that the +138 I/D polymorphism is of functional importance for ET-1 expression, and this may have consequences for vessel tonus regulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12893982     DOI: 10.1097/00008571-200308000-00002

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  14 in total

Review 1.  Endothelin-1 gene regulation.

Authors:  Lisa R Stow; Mollie E Jacobs; Charles S Wingo; Brian D Cain
Journal:  FASEB J       Date:  2010-09-13       Impact factor: 5.191

2.  Endothelin-1 and endothelial nitric oxide polymorphisms in idiopathic pulmonary arterial hypertension.

Authors:  Shivani Vadapalli; H Surekha Rani; Bks Sastry; Pratibha Nallari
Journal:  Int J Mol Epidemiol Genet       Date:  2010-06-15

3.  Expression of the nfa1 gene cloned from pathogenic Naegleria fowleri in nonpathogenic N. gruberi enhances cytotoxicity against CHO target cells in vitro.

Authors:  Seok-Ryoul Jeong; Sang-Chul Lee; Kyoung-Ju Song; Sun Park; Kyongmin Kim; Myung-Hee Kwon; Kyung-Il Im; Ho-Joon Shin
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

4.  Analysis of endothelin-1 and endothelin-1 receptor A gene polymorphisms in patients with pulmonary arterial hypertension.

Authors:  Paolo Calabrò; Giuseppe Limongelli; Valeria Maddaloni; Carmine Dario Vizza; Michele D'Alto; Raffaella D'Alessandro; Roberto Poscia; Paola Argiento; Brunella Ziello; Roberto Badagliacca; Emanuele Romeo; Giuseppe Pacileo; Maria Giovanna Russo; Francesco Fedele; Raffaele Calabrò
Journal:  Intern Emerg Med       Date:  2011-07-20       Impact factor: 3.397

5.  Effects of two common polymorphisms in the 3' untranslated regions of estrogen receptor beta on mRNA stability and translatability.

Authors:  Milica Putnik; Chunyan Zhao; Jan-Ake Gustafsson; Karin Dahlman-Wright
Journal:  BMC Genet       Date:  2009-09-15       Impact factor: 2.797

6.  Endothelin receptor polymorphisms in the cardiovascular system: potential implications for therapy and screening.

Authors:  Luise Holzhauser; Ronald Zolty
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

7.  Endothelin system polymorphisms in tilt test-induced vasovagal syncope.

Authors:  Sandro Sorrentino; Cinzia Forleo; Massimo Iacoviello; Pietro Guida; Valentina D'Andria; Stefano Favale
Journal:  Clin Auton Res       Date:  2009-02-19       Impact factor: 4.435

8.  Endothelin system polymorphisms in tilt test-induced vasovagal syncope.

Authors:  Sandro Sorrentino; Cinzia Forleo; Massimo Iacoviello; Pietro Guida; Valentina D'Andria; Stefano Favale
Journal:  Clin Auton Res       Date:  2009-04-15       Impact factor: 4.435

9.  Microarray analysis of multiple candidate genes and associated plasma proteins for nephropathy secondary to type 2 diabetes among Chinese individuals.

Authors:  S C Lim; J J Liu; H Q Low; N G Morgenthaler; Y Li; L Y Yeoh; Y S Wu; S K Goh; C Y Chionh; S H Tan; Y C Kon; P C Soon; Y M Bee; T Subramaniam; C F Sum; K S Chia
Journal:  Diabetologia       Date:  2009-05-05       Impact factor: 10.122

10.  In vivo assessment of a single adenine mutation in 5'UTR of Endothelin-1 gene in paediatric cases with severe pulmonary hypertension: an observational study.

Authors:  Sakshi Dhingra Batra; Kriti Sikri; Abhishek Kumar; Minati Choudhury; Anushree Gupta
Journal:  BMC Res Notes       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.